Dentists in Ft Riley, KS Accepting Medicare
5 Dentists found. Showing 1 - 5
 Dr. Charles Brandon Webber, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 650 Huebner Rd, Ft Riley, KS 66442 Phone: 785-240-7411 |
 Elena Gabriela Furdui-carr, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 600 Caisson Hill Rd, Ft Riley, KS 66442 Phone: 785-239-7241 |
Dr. John Howard Gittins, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 600 Caisson Hill Rd, Usa Dentac, Ft Riley, KS 66442 Phone: 785-238-7241 Fax: 785-240-5749 |
Dr. Brandon Wolf, D.M.D Dentist Medicare: Not Enrolled in Medicare Practice Location: 600 Caisson Hill Rd, Ft Riley, KS 66442 Phone: 330-502-7292 |
Curtis Benedetto, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 228 Beeman Pl, Ft Riley, KS 66442 Phone: 785-239-7247 |
News Archive
Emerging-disease hotpsots mapped
An international research team has provided the first scientific evidence that deadly emerging diseases have risen steeply across the world, and has mapped the outbreaks' main sources.
Experts urge McDonald's to stop marketing junk food to kids
McDonald's has incurred the wrath of over 550 health professionals and organizations who have signed a letter to McDonald's Corp. asking the maker of Happy Meals to stop marketing junk food to kids and retire Ronald McDonald.
Researchers investigate link between the liver's immune system composition and NASH pathology
Our livers work hard to perform an entire range of activities: helping us digest food, maintaining body temperature and serving as an important checkpoint of the immune system for everything that we eat.
Study: Immunotherapy shows promising response rate in patients with metastatic gastric cancer
Pembrolizumab has shown a promising response rate in patients with pretreated metastatic gastric cancer, according to late-breaking results from the KEYNOTE-059 trial presented today at the ESMO 2017 Congress in Madrid.
Stapled Peptides can inhibit key intracellular biological targets, says new research
Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collaborators, James E. Bradner, MD of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, PhD, Professor of Chemistry at Harvard University, published research in Nature entitled, "Direct Inhibition of the Notch Transcription Factor Complex." Results presented in the paper showed that Stapled Peptides can potently and directly inhibit the transcription factor Notch, an oncogene implicated in cancer cell proliferation and survival.
› Verified 8 days ago
Pharmacists
Dentists
Counselors
Occupational Therapists
Clinical Social Workers
Psychologists